Press Releases

INCLINE VILLAGE, Nev. , May 4, 2016 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) ( NASDAQ : PDLI) today reported financial results for the first quarter ended March 31, 2016 including: Total revenues of $103.1 million for the first quarter of 2016. Non-GAAP diluted earnings per share (EPS) of $0.52

INCLINE VILLAGE, Nev. , May 4, 2016 /PRNewswire/ -- PDL BioPharma, Inc. ( NASDAQ : PDLI) today announced that its board of directors has declared a $0.05 per share dividend for the second quarter of 2016.  The cash dividend will be paid on June 13, 2016 to all stockholders who own shares of PDL on

INCLINE VILLAGE, Nev. , April 28, 2016 /PRNewswire/ --  PDL BioPharma, Inc. (PDL) ( NASDAQ : PDLI) today announced that the Company will release its first quarter 2016 financial results for the period ended March 31, 2016 , on Wednesday, May 4, 2016 , after market close.

INCLINE VILLAGE, Nev. , March 31, 2016 /PRNewswire/ -- PDL BioPharma, Inc. (PDL or the Company) ( NASDAQ : PDLI) today announced that the Company will hold its annual meeting of stockholders on Thursday, June 2, 2016 , at 10:00 a.m. Pacific Time for all stockholders of record on April 8, 2016 .

INCLINE VILLAGE, Nev. , March 14, 2016 /PRNewswire/ --  PDL BioPharma, Inc. (PDL) ( NASDAQ : PDLI) today announced that it has paid the March 11, 2016 , quarterly dividend payment of $0.05 per share to all stockholders owning shares of PDL as of March 4, 2016 , the record date.

INCLINE VILLAGE, Nev. , March 2, 2016 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) ( NASDAQ : PDLI) today announced that John P. McLaughlin , the company's president and chief executive officer, will present at the Cowen and Company 36 th Annual Health Care Conference next week in Boston .

- Record Annual and Quarterly Revenues Achieved -
- Nine Percent Annual EPS Growth -

INCLINE VILLAGE, Nev. , Feb. 17, 2016 /PRNewswire/ --  PDL BioPharma, Inc. (PDL) ( NASDAQ : PDLI) today announced that John P. McLaughlin , the company's president and chief executive officer, will present at the 2016 RBC Capital Markets' Healthcare Conference next week in New York City .

INCLINE VILLAGE, Nev. , Feb. 16, 2016 /PRNewswire/ --  PDL BioPharma, Inc. (PDL) ( NASDAQ : PDLI) today announced that the Company will release its fourth quarter and full year 2015 financial results for the period ended December 31, 2015 , on Monday, February 22, 2016 , after market close.

INCLINE VILLAGE, Nev. , Feb. 2, 2016 /PRNewswire/ --   PDL BioPharma, Inc. (PDL) ( NASDAQ : PDLI) today announced that John P. McLaughlin , the company's president and chief executive officer, will present at the 2016 BIO CEO & Investor Conference next week in New York City .

-- Company Shifts to Quarterly Assessment of Dividends to Capitalize on Long-Term Growth Opportunities --
-- Webcast Call to be Held Today at 5:00pm EST --

LENSAR, Inc.'s Assets Acquired by a Subsidiary of ALPHAEON Corporation

INCLINE VILLAGE, Nev. , Dec. 14, 2015 /PRNewswire/ --  PDL BioPharma, Inc. (PDL) ( NASDAQ : PDLI) today announced that it has paid the December 11, 2015 , regular quarterly dividend payment of $0.15 per share to all stockholders owning shares of PDL as of December 4, 2015 , the record date.

INCLINE VILLAGE, Nev. , Dec. 2, 2015 /PRNewswire/ --   PDL BioPharma, Inc. (PDL) ( NASDAQ : PDLI) today acknowledges receipt of $133.7 million in notable cash payments from November 1, 2015 through December 1, 2015 . PDL does not typically report individual payments such as these, but given the

INCLINE VILLAGE, Nev. , Nov. 24, 2015 /PRNewswire/ --  PDL BioPharma, Inc. (PDL) ( NASDAQ : PDLI) today announced that John P. McLaughlin , the company's president and chief executive officer, will present at the 27 th Annual Piper Jaffray Healthcare Conference next week in New York City .